骨痛治療の世界市場レポート 2025年

骨痛治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.3％で80億1,000万米ドルに成長します。予測期間の成長は、骨疼痛の標的生物学的療法に対する需要の増加、非侵襲的治療オプションへの嗜好の高まり、骨疼痛管理における個別化医療の採用拡大、市販鎮痛剤の需要拡大、新興市場におけるヘルスケアへのアクセス改善などに起因すると考えられます。この期間に予想される主要動向には、骨疼痛管理における人工知能の統合、疼痛緩和のための仮想現実の利用、骨粗鬆症性骨疼痛の治療における進歩、技術強化型疼痛緩和装置の開発、クロスセラピーの統合、外科的介入におけるロボット工学の導入などがあります。

骨粗鬆症の有病率の増加は、今後骨痛治療市場の成長を促進すると予想されます。骨粗鬆症は、骨密度や強度が低下することで骨がもろくなり、骨折しやすくなる疾患です。骨密度は一般的に加齢とともに低下するため、この疾患は主に世界人口の高齢化により一般的になりつつあります。骨疼痛治療は、骨粗鬆症に伴う不快感を和らげ、運動能力を向上させ、生活の質の向上をサポートすることで、骨粗鬆症の疼痛管理に重要な役割を果たしています。例えば、2024年6月、オーストラリア保健福祉ラボは、2022年にはオーストラリアで約85万3,600人が骨粗鬆症または骨減少症に罹患しており、同年の死亡者数は2,659人であったと報告しました。したがって、骨粗鬆症の有病率の上昇は、効果的な骨痛治療に対する需要を大きく促進しています。

骨痛治療市場で事業を展開する主要企業は、処方箋付きウェアラブル機器など、標的を絞った疼痛緩和を実現する革新的ソリューションの開発に注力しています。これらの医療認可デバイスは身体に装着し、電気刺激や振動などの療法を提供することで、血行を促進したり、炎症を抑えたり、痛みの信号を遮断したりして骨の痛みを緩和します。例えば、2025年5月、米国の医療機器メーカーであるオステオブーストヘルス社は、骨密度の低い人のために特別に設計された初のFDA認可ウェアラブル機器であるオステオブーストを発売しました。このウェアラブルベルトは、低振幅の高周波振動療法（20～40Hz）を脊椎と臀部に与え、骨減少症の閉経後女性の骨密度と強度の低下を遅らせることを目的としています。通常の活動中に毎日30分間使用できるように設計されており、Osteoboostは、重大な有害事象なしに骨の健康を維持する臨床的有効性を実証しています。オステオブーストは、電動振動パック、圧力センサ、加速度計を内蔵しており、正確で安全な治療を行うことができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の骨痛治療：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の骨痛治療市場：成長率分析
• 世界の骨痛治療市場の実績：規模と成長、2019～2024年
• 世界の骨痛治療市場の予測：規模と成長、2024～2029年、2034年
• 世界の骨痛治療：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の骨痛治療市場治療タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬剤療法
• 非薬剤療法
• 外科的介入
• 世界の骨痛治療市場：薬剤クラス別、実績と予測、2019～2024年、2024～2029年、2034年
• 鎮痛剤
• 抗うつ薬
• 抗けいれん薬
• コルチコステロイド
• 世界の骨痛治療市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• けが
• 感染
• 筋肉痛
• 腫瘍
• 世界の骨痛治療市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 直接販売
• 小売薬局
• オンライン薬局
• 世界の骨痛治療市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 在宅ケア
• 世界の骨痛治療市場、薬剤療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 非ステロイド性抗炎症薬（NSAID）
• オピオイド
• コルチコステロイド
• 抗けいれん薬
• 抗うつ薬
• 世界の骨痛治療市場、非薬剤療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 理学療法
• 鍼
• カイロプラクティックケア
• 認知行動療法（CBT）
• 経皮的電気神経刺激（TENS）
• 世界の骨痛治療市場、外科的介入のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 関節置換手術
• 脊椎固定術
• 椎体形成術と後弯形成術
• 腫瘍切除
• デブリードマン手術

第7章 地域別・国別分析

• 世界の骨痛治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の骨痛治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 骨痛治療市場：競合情勢
• 骨痛治療市場：企業プロファイル
  • Pfizer Inc.
  • Johnson and Johnson
  • F. Hoffmann-La Roche Ltd.
  • Merck and Co. Inc.
  • Bayer AG

第31章 その他の大手企業と革新的企業

• Sanofi S.A
• Bristol-Myers Squibb Company
• Novartis International AG
• GSK plc
• Medtronic plc
• Eli Lilly and Company
• Amgen Inc.
• Stryker Corporation
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Astellas Pharma Inc.
• Endo International plc
• Amneal Pharmaceuticals Inc.
• Marksans Pharma Limited
• APS Materials Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 骨痛治療市場、2029年：新たな機会を提供する国
• 骨痛治療市場、2029年：新たな機会を提供するセグメント
• 骨痛治療市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Bone pain treatment involves medical interventions aimed at relieving discomfort or aching in the bones, which may result from conditions such as fractures, infections, cancer, or chronic illnesses. These treatments typically encompass medications, physical therapy, and, in some cases, surgical procedures to target the root cause and mitigate pain.

The primary categories of bone pain treatment include pharmacological treatments, non-pharmacological approaches, and surgical interventions. Pharmacological treatments involve the use of drugs to prevent, manage, or treat medical conditions by influencing specific biological functions. The drug classes commonly employed include analgesics, antidepressants, anticonvulsants, and corticosteroids. Bone pain is generally treated for conditions such as injuries, infections, myalgia, and tumors. Treatment options are distributed via direct sales, retail pharmacies, and online pharmacies, and are used by end users such as hospitals, clinics, and homecare settings.

The bone pain treatment market research report is one of a series of new reports from The Business Research Company that provides bone pain treatment market statistics, including the bone pain treatment industry's global market size, regional shares, competitors with the bone pain treatment market share, detailed bone pain treatment market segments, market trends and opportunities, and any further data you may need to thrive in the bone pain treatment market. This bone pain treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bone pain treatment market size has grown strongly in recent years. It will grow from $5.62 billion in 2024 to $6.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period can be attributed to the rising prevalence of chronic conditions such as osteoporosis and arthritis, a surge in bone disorder cases, an expanding elderly population, increasing awareness regarding bone health, and a higher incidence of cancer-related bone metastases.

The bone pain treatment market size is expected to see strong growth in the next few years. It will grow to $8.01 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing demand for targeted biologic therapies for bone pain, rising preference for non-invasive treatment options, the expanding adoption of personalized medicine in bone pain management, growing demand for over-the-counter pain relievers, and improved access to healthcare in emerging markets. Key trends anticipated during this period include the integration of artificial intelligence in bone pain management, the use of virtual reality for pain relief, advancements in treatments for osteoporotic bone pain, the development of technology-enhanced pain relief devices, cross-therapy integration, and the incorporation of robotics in surgical interventions.

The increasing prevalence of osteoporosis is expected to propel the growth of the bone pain treatment market going forward. Osteoporosis is a condition marked by reduced bone density and strength, making bones more fragile and susceptible to fractures. This condition is becoming more common, primarily due to the aging global population, as bone density typically decreases with age. Bone pain treatments play a critical role in managing osteoporosis by relieving associated discomfort, improving mobility, and supporting better quality of life. For instance, in June 2024, the Australian Institute of Health and Welfare reported that approximately 853,600 individuals in Australia were living with osteoporosis or osteopenia in 2022, with the disease contributing to 2,659 deaths that year. Therefore, the rising prevalence of osteoporosis is significantly driving the demand for effective bone pain treatments.

Major companies operating in the bone pain treatment market are focusing on developing innovative solutions, such as prescription wearable devices, to deliver targeted pain relief. These medically approved devices are worn on the body and offer therapies like electrical stimulation or vibration to alleviate bone pain by enhancing circulation, reducing inflammation, or disrupting pain signals. For instance, in May 2025, Osteoboost Health Inc., a US-based medical equipment manufacturer, launched Osteoboost, the first FDA-cleared wearable device specifically designed for individuals with low bone density. This wearable belt delivers low-amplitude, high-frequency vibration therapy (20-40 Hz) to the spine and hips and is intended to slow the loss of bone density and strength in postmenopausal women with osteopenia. Designed for daily 30-minute use during normal activities, Osteoboost has demonstrated clinical efficacy in preserving bone health without significant adverse events. The device integrates a motorized vibration pack, pressure sensor, and accelerometers to ensure precise and safe therapy delivery.

In November 2023, Boston Scientific Corporation, a US-based biotechnology company, acquired Relievant Medsystems Inc. for $850 million. This strategic acquisition was aimed at expanding Boston Scientific's chronic pain management portfolio and reinforcing its leadership in the interventional pain space. By integrating Relievant's innovative, FDA-cleared solutions, the company seeks to enhance patient access to effective treatments and improve clinical outcomes. Relievant Medsystems Inc., also based in the US, specializes in treating chronic low back pain, with a particular focus on vertebrogenic pain, offering targeted therapies that address the underlying source of pain.

Major players in the bone pain treatment market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, Novartis International AG, GSK plc, Medtronic plc, Eli Lilly and Company, Amgen Inc., Stryker Corporation, Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Endo International plc, Amneal Pharmaceuticals Inc., Marksans Pharma Limited, and APS Materials Inc.

North America was the largest region in the bone pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bone pain treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bone pain treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bone pain treatment market includes revenues earned by entities by providing services such as pharmacological therapy services, physical therapy and rehabilitation services, surgical intervention services, pain management clinics, and diagnostic imaging and evaluation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bone pain treatment also includes sales of acetaminophen, ibuprofen, naproxen, morphine, oxycodone, alendronate, and prednisone. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bone Pain Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bone pain treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bone pain treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bone pain treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Pharmacological Treatments; Non-Pharmacological Treatments; Surgical Interventions
• 2) By Drug Class: Analgesics; Antidepressants; Anticonvulsants; Corticosteroids
• 3) By Indication: Injury; Infection; Myalgia; Tumors
• 4) By Distribution Channel: Direct Sales; Retail Pharmacies; Online Pharmacies
• 5) By End-User: Hospitals; Clinics; Homecare Settings
• Subsegments:
• 1) By Pharmacological Treatments: Nonsteroidal Anti-inflammatory Drugs (NSAIDs); Opioids; Corticosteroids; Anticonvulsants; Antidepressants
• 2) By Non-Pharmacological Treatments: Physical Therapy; Acupuncture; Chiropractic Care; Cognitive Behavioral Therapy (CBT); Transcutaneous Electrical Nerve Stimulation
• 3) By Surgical Interventions: Joint Replacement Surgery; Spinal Fusion; Vertebroplasty And Kyphoplasty; Tumor Resection; Debridement Surgery
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson; F. Hoffmann-La Roche Ltd.; Merck and Co. Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bone Pain Treatment Market Characteristics

3. Bone Pain Treatment Market Trends And Strategies

4. Bone Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bone Pain Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bone Pain Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bone Pain Treatment Market Growth Rate Analysis
• 5.4. Global Bone Pain Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bone Pain Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bone Pain Treatment Total Addressable Market (TAM)

6. Bone Pain Treatment Market Segmentation

• 6.1. Global Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacological Treatments
• Non-Pharmacological Treatments
• Surgical Interventions
• 6.2. Global Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analgesics
• Antidepressants
• Anticonvulsants
• Corticosteroids
• 6.3. Global Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injury
• Infection
• Myalgia
• Tumors
• 6.4. Global Bone Pain Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Sales
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Bone Pain Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare Settings
• 6.6. Global Bone Pain Treatment Market, Sub-Segmentation Of Pharmacological Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Opioids
• Corticosteroids
• Anticonvulsants
• Antidepressants
• 6.7. Global Bone Pain Treatment Market, Sub-Segmentation Of Non-Pharmacological Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Therapy
• Acupuncture
• Chiropractic Care
• Cognitive Behavioral Therapy (CBT)
• Transcutaneous Electrical Nerve Stimulation (TENS)
• 6.8. Global Bone Pain Treatment Market, Sub-Segmentation Of Surgical Interventions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Joint Replacement Surgery
• Spinal Fusion
• Vertebroplasty And Kyphoplasty
• Tumor Resection
• Debridement Surgery

7. Bone Pain Treatment Market Regional And Country Analysis

• 7.1. Global Bone Pain Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bone Pain Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bone Pain Treatment Market

• 8.1. Asia-Pacific Bone Pain Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bone Pain Treatment Market

• 9.1. China Bone Pain Treatment Market Overview
• 9.2. China Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bone Pain Treatment Market

• 10.1. India Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bone Pain Treatment Market

• 11.1. Japan Bone Pain Treatment Market Overview
• 11.2. Japan Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bone Pain Treatment Market

• 12.1. Australia Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bone Pain Treatment Market

• 13.1. Indonesia Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bone Pain Treatment Market

• 14.1. South Korea Bone Pain Treatment Market Overview
• 14.2. South Korea Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bone Pain Treatment Market

• 15.1. Western Europe Bone Pain Treatment Market Overview
• 15.2. Western Europe Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bone Pain Treatment Market

• 16.1. UK Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bone Pain Treatment Market

• 17.1. Germany Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bone Pain Treatment Market

• 18.1. France Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bone Pain Treatment Market

• 19.1. Italy Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bone Pain Treatment Market

• 20.1. Spain Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bone Pain Treatment Market

• 21.1. Eastern Europe Bone Pain Treatment Market Overview
• 21.2. Eastern Europe Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bone Pain Treatment Market

• 22.1. Russia Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bone Pain Treatment Market

• 23.1. North America Bone Pain Treatment Market Overview
• 23.2. North America Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bone Pain Treatment Market

• 24.1. USA Bone Pain Treatment Market Overview
• 24.2. USA Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bone Pain Treatment Market

• 25.1. Canada Bone Pain Treatment Market Overview
• 25.2. Canada Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bone Pain Treatment Market

• 26.1. South America Bone Pain Treatment Market Overview
• 26.2. South America Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bone Pain Treatment Market

• 27.1. Brazil Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bone Pain Treatment Market

• 28.1. Middle East Bone Pain Treatment Market Overview
• 28.2. Middle East Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bone Pain Treatment Market

• 29.1. Africa Bone Pain Treatment Market Overview
• 29.2. Africa Bone Pain Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bone Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bone Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bone Pain Treatment Market Competitive Landscape And Company Profiles

• 30.1. Bone Pain Treatment Market Competitive Landscape
• 30.2. Bone Pain Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Bone Pain Treatment Market Other Major And Innovative Companies

• 31.1. Sanofi S.A
• 31.2. Bristol-Myers Squibb Company
• 31.3. Novartis International AG
• 31.4. GSK plc
• 31.5. Medtronic plc
• 31.6. Eli Lilly and Company
• 31.7. Amgen Inc.
• 31.8. Stryker Corporation
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Mylan N.V.
• 31.11. Astellas Pharma Inc.
• 31.12. Endo International plc
• 31.13. Amneal Pharmaceuticals Inc.
• 31.14. Marksans Pharma Limited
• 31.15. APS Materials Inc.

32. Global Bone Pain Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bone Pain Treatment Market

34. Recent Developments In The Bone Pain Treatment Market

35. Bone Pain Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Bone Pain Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bone Pain Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bone Pain Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer